<DOC>
	<DOC>NCT00330395</DOC>
	<brief_summary>The purpose of this study is to test the amount of caspofungin found in the blood of neonate and infants &lt;3 months of age following treatment with caspofungin at 25 mg/m2. Another purpose is to test the safety of caspofungin in treating neonates and infants with Candida infections (a certain type of fungal infection).</brief_summary>
	<brief_title>Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Neonates and infants &lt;3 months of age Patient has a body weight greater than or equal to 500 grams Patient has documented or highly suspected Candida infection Patient is greater than 3 months of age Patient has a body weight of less than 500 grams Patient does not meet certain laboratory testing criteria Patient is hemodynamically unstable, exhibits hemodynamic compromise or is not expected to survive at least 5 days Patient has documented HIV infection of any stage Patient has a history of allergy, hypersensitivity, or serious reaction to caspofungin or another member of the echinocandin class</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>